Literature DB >> 19896927

Modulation of human placental P-glycoprotein expression and activity by MDR1 gene polymorphisms.

Sarah J Hemauer1, Tatiana N Nanovskaya, Sherif Z Abdel-Rahman, Svetlana L Patrikeeva, Gary D V Hankins, Mahmoud S Ahmed.   

Abstract

The ABC transporter P-glycoprotein is a product of the MDR1 gene and its function in human placenta is to extrude xenobiotics from the tissue thus decreasing fetal exposure. The goal of this investigation was to examine the effect of three polymorphisms in the MDR1 gene on the expression and activity of placental P-gp. In 199 term placentas examined, the C1236T variant was associated with 11% lower P-gp protein expression than wild-type, while the C3435T and G2677T/A variants each were associated with a 16% reduction (p<0.05). Homozygotes for the C1236T and C3435T variant allele (TT) were associated with 42% and 47% increase in placental P-gp transport activity, respectively (p=0.04 and p=0.02) of the prototypic substrate, [(3)H]-paclitaxel. These findings indicate that the C3435T and G2677T/A SNPs in MDR1 are significantly associated with decreased placental P-gp protein expression, while the C1236T and C3245T homozygous variants are significantly associated with an increase in its efflux activity. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19896927      PMCID: PMC2812613          DOI: 10.1016/j.bcp.2009.10.026

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  27 in total

1.  Three hundred twenty-six genetic variations in genes encoding nine members of ATP-binding cassette, subfamily B (ABCB/MDR/TAP), in the Japanese population.

Authors:  Susumu Saito; Aritoshi Iida; Akihiro Sekine; Yukie Miura; Chie Ogawa; Saori Kawauchi; Shoko Higuchi; Yusuke Nakamura
Journal:  J Hum Genet       Date:  2002       Impact factor: 3.172

2.  Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene.

Authors:  M Tanabe; I Ieiri; N Nagata; K Inoue; S Ito; Y Kanamori; M Takahashi; Y Kurata; J Kigawa; S Higuchi; N Terakawa; K Otsubo
Journal:  J Pharmacol Exp Ther       Date:  2001-06       Impact factor: 4.030

3.  The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells.

Authors:  M Hitzl; S Drescher; H van der Kuip; E Schäffeler; J Fischer; M Schwab; M Eichelbaum; M F Fromm
Journal:  Pharmacogenetics       Date:  2001-06

Review 4.  Subcellular detection and localization of the drug transporter P-glycoprotein in cultured tumor cells.

Authors:  A Molinari; A Calcabrini; S Meschini; A Stringaro; P Crateri; L Toccacieli; M Marra; M Colone; M Cianfriglia; G Arancia
Journal:  Curr Protein Pept Sci       Date:  2002-12       Impact factor: 3.272

5.  Kinetic analysis of P-glycoprotein-mediated transport by using normal human placental brush-border membrane vesicles.

Authors:  Fumihiko Ushigome; Noriko Koyabu; Shoji Satoh; Kiyomi Tsukimori; Hitoo Nakano; Takanori Nakamura; Takeshi Uchiumi; Michihiko Kuwano; Hisakazu Ohtani; Yasufumi Sawada
Journal:  Pharm Res       Date:  2003-01       Impact factor: 4.200

6.  Opiates inhibit paclitaxel uptake by P-glycoprotein in preparations of human placental inside-out vesicles.

Authors:  Sarah J Hemauer; Svetlana L Patrikeeva; Tatiana N Nanovskaya; Gary D V Hankins; Mahmoud S Ahmed
Journal:  Biochem Pharmacol       Date:  2009-07-08       Impact factor: 5.858

Review 7.  P-glycoprotein: from genomics to mechanism.

Authors:  Suresh V Ambudkar; Chava Kimchi-Sarfaty; Zuben E Sauna; Michael M Gottesman
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

8.  Irinotecan pathway genotype analysis to predict pharmacokinetics.

Authors:  Ron H J Mathijssen; Sharon Marsh; Mats O Karlsson; Rujia Xie; Sharyn D Baker; Jaap Verweij; Alex Sparreboom; Howard L McLeod
Journal:  Clin Cancer Res       Date:  2003-08-15       Impact factor: 12.531

9.  Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene.

Authors:  Deanna L Kroetz; Christiane Pauli-Magnus; Laura M Hodges; Conrad C Huang; Michiko Kawamoto; Susan J Johns; Doug Stryke; Thomas E Ferrin; Joseph DeYoung; Travis Taylor; Elaine J Carlson; Ira Herskowitz; Kathleen M Giacomini; Andrew G Clark
Journal:  Pharmacogenetics       Date:  2003-08

10.  Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo.

Authors:  S Hoffmeyer; O Burk; O von Richter; H P Arnold; J Brockmöller; A Johne; I Cascorbi; T Gerloff; I Roots; M Eichelbaum; U Brinkmann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more
  28 in total

1.  P-glycoprotein gene MDR1 polymorphisms and susceptibility to systemic lupus erythematosus in Guangxi population: a case-control study.

Authors:  Jian Wang; Yanqiong Liu; Jiangyang Zhao; Juanjuan Xu; Shan Li; Xue Qin
Journal:  Rheumatol Int       Date:  2017-02-02       Impact factor: 2.631

2.  Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin.

Authors:  Sarah J Hemauer; Svetlana L Patrikeeva; Tatiana N Nanovskaya; Gary D V Hankins; Mahmoud S Ahmed
Journal:  Am J Obstet Gynecol       Date:  2010-04       Impact factor: 8.661

3.  Association between MDR1 gene polymorphisms and the risk of Crohn's disease in a cohort of Algerian pediatric patients.

Authors:  Amira Bouzidi; Hamida Mesbah-Amroun; Aziza Boukercha; Fadila Benhassine; Réda Belboueb; Karima Berkouk; Wassila Messadi; Chafia Touil-Boukoffa
Journal:  Pediatr Res       Date:  2016-09-07       Impact factor: 3.756

4.  In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome.

Authors:  Bryce A Griffin; Caitlin O Caperton; Lauren N Russell; Christian V Cabanlong; Catheryn D Wilson; Kyle R Urquhart; Bradford S Martins; Marcelle Dina Zita; Amy L Patton; Alexander W Alund; S Michael Owens; William E Fantegrossi; Jeffery H Moran; Lisa K Brents
Journal:  J Pharmacol Exp Ther       Date:  2019-04-26       Impact factor: 4.030

5.  Differential effect of ABCB1 haplotypes on promoter activity.

Authors:  Jordan T Speidel; Meixiang Xu; Sherif Z Abdel-Rahman
Journal:  Pharmacogenet Genomics       Date:  2018-03       Impact factor: 2.089

Review 6.  Placental ABC Transporters: Biological Impact and Pharmaceutical Significance.

Authors:  Anand A Joshi; Soniya S Vaidya; Marie V St-Pierre; Andrei M Mikheev; Kelly E Desino; Abner N Nyandege; Kenneth L Audus; Jashvant D Unadkat; Phillip M Gerk
Journal:  Pharm Res       Date:  2016-09-19       Impact factor: 4.200

7.  Concentration-dependent effects and intracellular accumulation of HIV protease inhibitors in cultured CD4 T cells and primary human lymphocytes.

Authors:  Omar Janneh; Patrick G Bray; Elizabeth Jones; Christoph Wyen; Peter Chiba; David J Back; Saye H Khoo
Journal:  J Antimicrob Chemother       Date:  2010-03-17       Impact factor: 5.790

Review 8.  ATP-binding cassette efflux transporters in human placenta.

Authors:  Zhanglin Ni; Qingcheng Mao
Journal:  Curr Pharm Biotechnol       Date:  2011-04       Impact factor: 2.837

Review 9.  Genetic determinants of fetal opiate exposure and risk of neonatal abstinence syndrome: Knowledge deficits and prospects for future research.

Authors:  T Lewis; J Dinh; J S Leeder
Journal:  Clin Pharmacol Ther       Date:  2015-07-22       Impact factor: 6.875

10.  Maternal medication use, fetal 3435 C>T polymorphism of the ABCB1 gene, and risk of isolated septal defects in a Han Chinese population.

Authors:  Chuan Wang; Kaiyu Zhou; Liang Xie; Yifei Li; Yalan Zhan; Lina Qiao; Chaoyi Qin; Ruiqi Liu; Yimin Hua
Journal:  Pediatr Cardiol       Date:  2014-04-17       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.